Feb 10, 2026 | Benefits Advisory Conference, Benefits management, Cancer, Caroline Fraker, Compliance, Forensic claims review, Gene therapy, GLP-1s, High-cost claims, MedBen University, No Surprises Act (NSA), Obesity, Orphan diseases, Pharmacy, Specialty Drugs, Stop-Loss, Transplants
Consultants and advisors from 10 different states attended the MedBen 2026 Benefits Advisory Conference on January 28. The event featured insights from some of the industry’s most respected voices and gave brokers a clearer view of today’s benefits landscape, what...
Apr 22, 2025 | Compliance, Genomics, MedBen University, Mental health parity, Roundtables, Stop-Loss, Wellness
Nearly 50 clients and brokers attended the MedBen University (MBU) 2025 Employer Roundtable on April 9. Industry professionals from MedBen, Sun Life, and Profero Team provided attendees with outside-the-box ways to blend benefits management and employee well-being,...
Feb 25, 2025 | Announcements, Benchmarks, Case Studies, Compliance, Genomics, MedBen University, Wellness
The 24th season of MedBen University (MBU) is in session! MBU will be conducting an Employer Roundtable on Wednesday, April 9… so take a moment to save the date! Topics to be covered at the roundtable include: A review of industry cost benchmarks and benefit...
Feb 11, 2025 | Benefits Advisory Conference, Benefits management, Caroline Fraker, Compliance, Forensic claims review, MedBen University, No Surprises Act (NSA), Pharmacy, Stop-Loss, Wellness
Over 70 guests from seven states attended the MedBen 2025 Benefits Advisory Conference on January 30. Featuring some of the most respected names in the industry, this invitation-only event provided brokers with an extensive look at the state of benefits...
May 13, 2024 | Diabetes, Kurt Harden, MedBen Rx, MedBen University, Mounjaro, Ozempic, Wegovy, Weight loss, Zepbound
At recent MedBen University roundtables, MedBen President & CEO Kurt Harden examined how the growing public awareness of two diabetes drugs with a desirable side effect – significant weight loss – means that these $1,000-per-month medications are not always being...
Apr 30, 2024 | Alternative Reimbursement Strategies, Biosimilars, Brian Fargus, Brooke Hupp, Caroline Fraker, Fair market reimbursement, Kurt Harden, MedBen Rx, MedBen University, Mental health parity, Municipalities, Nutrigenomics, Pharmacogenomics, Roundtables
At the 18th Annual MedBen University Municipality & Public Employer Roundtable on April 24, clients were shown how MedBen’s self-funding solutions are lowering medical and pharmacy spend while promoting healthier workplaces. Attendees were also introduced to...
